Updated April 22, 2019 09:08:53AUSTIN, Texas — When the Trump administration takes over health products like birth control, you can expect to see a lot more women buying Viagra and erectile dysfunction drugs like Viagra XR.
“The FDA has the authority to regulate the pharmaceutical industry,” said Dr. Jennifer L. Miller, a professor at the University of Texas Health Science Center at Houston and an expert in the pharmaceuticals industry.
“And if they decide to do that, then they’re going to be in a lot of trouble.
The FDA has been saying, ‘Let’s regulate this drug so it’s safer, so that it can be used more safely.'”
The FDA is currently taking over the entirety of the health products market, and some experts think the agency is poised to take over the whole health care industry.
“They will not be able to regulate any of the drugs that are used today, including those that are on the market today,” said Miller.
The FDA regulates the pharmaceutical products used in the United States.
It regulates the drug companies, which produce the drugs.
It oversees drug labels and regulations.
It reviews and approves the use of drugs, such as Viagra, for people over age 65.
“What the FDA is going to do is to have a completely different role,” said L. J. Smith, director of the Women’s Health Policy Institute at the National Women’s Law Center.
Smith and other experts said the FDA has no business regulating the entire healthcare industry, because the FDA was created to protect the public.
“That role was created by the Congress and was created for a reason.
And we think it’s important that it be given that same purpose,” said Smith.
“The FDA’s goal is to regulate drugs and other products, not regulate the entire industry.”
The FDA oversees drugs that treat conditions such as heart disease, diabetes and obesity, and regulates how people use the drugs, according to the agency.
The agency has also been accused of allowing drug companies to manipulate drug labeling.
“We’re seeing this regulatory change coming as part of the Trump Administration, and I think it will be a real game changer,” said Johnson.
Johnson and Johnson are not the only pharmaceutical companies to be affected.
The American Medical Association (AMA) issued a statement in support of the FDA.
“It is critical that the FDA does not take over a major industry that has been the source of significant advances in medicine and healthcare,” the AMA said.
The AMA’s statement comes as other groups have also called for an end to the FDA’s regulation of drugs.
The Center for Science in the Public Interest, a nonprofit advocacy group, is also advocating for an independent agency to review all drug safety and efficacy research.
“If the FDA were to regulate every aspect of the pharmaceutical and health products industry, it would be like regulating every aspect a movie or a television show,” said J. Michael Collins, the executive director of Science Policy Alliance.
“It’s a bad idea and it would result in unnecessary regulatory overreach.”
Collins said the AMA has been trying to get the FDA to end its regulation of pharmaceuticals for years.
“I would love to see the FDA make the decisions about drug safety, but I think the AMA needs to be involved in that,” he said.
Some people who are concerned about the potential of the government regulating the healthcare industry said they hope the agency doesn’t take the agency’s actions too far.
“People who want to talk about the end of the drug industry, they should talk about other industries that are regulated by the FDA,” said James O’Keefe, a senior vice president at Public Citizen.
“There are people in other industries who have the same concerns.”
“There are a lot, but not a lot like there are in healthcare,” he added.